Medication compliance, adherence, and persistence: Current status of behavioral and educational interventions to improve outcomes

Journal of Managed Care Pharmacy

Volumn 14, Issue 6 SUPPL. D, 2008, Pages

  Touchette, Daniel R ^a   Shapiro, Nancy L ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; ANTIULCER AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISPHOSPHONIC ACID DERIVATIVE; CALCIUM CHANNEL BLOCKING AGENT; HEMOGLOBIN A1C; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NONSTEROID ANTIINFLAMMATORY AGENT; ORAL ANTIDIABETIC AGENT; PLACEBO; PSYCHOTROPIC AGENT;

ACUTE HEART INFARCTION; ASTHMA; CHRONIC DISEASE; CLINICAL TRIAL; COGNITION; CONGESTIVE HEART FAILURE; DIABETES MELLITUS; DRUG COST; DRUG EFFICACY; DRUG PACKAGING; DRUG SAFETY; DYSLIPIDEMIA; HEALTH CARE COST; HEALTH CARE NEED; HEALTH CARE UTILIZATION; HEALTH INSURANCE; HOSPITAL COST; HUMAN; HYPERTENSION; LIFE EXPECTANCY; LIFESTYLE MODIFICATION; LONG TERM CARE; MENTAL DISEASE; MORTALITY; MOTIVATION; PATIENT ATTITUDE; PATIENT COMPLIANCE; PATIENT EDUCATION; REVIEW; SELF MONITORING; SOCIAL SUPPORT; TREATMENT OUTCOME;

EID: 52249124501     PISSN: 10834087     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (70)

1. Haynes RB. Improving patient adherence: state of the art, with a special focus on medication taking for cardiovascular disorders. In: Burke LE, Ockene IS, eds. Compliance in Health Care and Research. New York, NY: Futura Publishing Co Inc; 2001:3-21.
2. Haynes RB, McDonald H, Garg AX. Interventions for helping patients to follow prescriptions for medications [Cochrane Review on CD-ROM]. Oxford, England: Cochrane Library, Update Software; 2002; issue 2.
3. Benner JS, Glynn RJ, Mogun H, Neumann PJ, Weinstein MC, Avorn J. Long-term persistence in use of statin therapy in elderly patients. JAMA. 2002;288:455-61.
4. Balkrishnan R. Predictors of medication adherence in the elderly. Clin Ther. 1998:20(4):764-71.
5. DiMatteo MR, Giordani PJ, Lepper HS, Croghan TW. Patient adherence and medical treatment outcomes: a meta-analysis. Med Care. 2002;40:794-811.
6. Sokol MC, McGuigan KA, Verbrugge RR, Epstein RS. Impact of medication adherence on hospitalization risk and health care cost. Med Care. 2005;43:521-30.
7. Balkrishnan R, Rajagopalan R, Camacho FT, Huston SA, Murray FT, Anderson RT. Predictors of medication adherence and associated health care costs in an older population with type 2 diabetes mellitus: a longitudinal cohort study. Clin Ther. 2003;25:2958-71.
8. Simpson SH, Eurich DT, Majumdar SR, et al. A meta-analysis of the association between adherence to drug therapy and mortality. BMJ. 2006;333(7557):15.
9. Rasmussen JN, Chong A, Alter DA. Relationship between adherence to evidence-based pharmacotherapy and long-term mortality after acute myocardial infarction. JAMA. 2007;297:177-86.
10. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005;353:487-97.
11. McDonald HP, Garg AX, Haynes RB. Interventions to enhance patient adherence to medication prescriptions. JAMA. 2002;288:2868-79.
12. Krueger KP, Felkey BG, Berger BA. Improving adherence and persistence: a review and assessment of interventions and description of steps toward a national adherence initiative. J Am Pharm Assoc. 2003; 43(6):668-78.
13. Vik SA, Maxwell CJ, Hogan DB. Measurement, correlates, and health outcomes of medication adherence among seniors. Ann Pharmacother. 2004;38:303-12.
14. DiMatteo MR, Haskard KB, Williams SL. Health beliefs, disease severity, and patient adherence: a meta-analysis. Med Care. 2007;45:521-28.
15. McHorney CA, Schousboe JT, Cline RR, Weiss TW. The impact of osteoporosis medication beliefs and side-effect experiences on non-adherence to oral bisphosphonates. Curr Med Res Opin. 2007:23:3137-31.
16. Cooper C, Bebbington P, King M, et al. Why people do not take their psychotropic drugs as prescribed: results of the 2000 National Psychiatric Morbidity Survey. Acta Psychiatr Scand. 2007:116:47-53.
17. Joyce GF, Escarce JJ, Solomon MD, Goldman DP. Employer drug benefit plans and spending on prescription drugs. JAMA. 2002;288:1733-39.
18. Goldman DP, Joyce GF, Zheng Y. Prescription drug cost sharing: associations with medication and medical utilization and spending and health. JAMA. 2007;298:61-69.
19. Tamblyn R, Laprise R, Hanley JA, et al. Adverse events associated with prescription drug cost-sharing among poor and elderly persons. JAMA. 2001;285:421-29.
20. Goldman DP, Joyce GF, Escarce JJ, et al. Pharmacy benefits and the use of drugs by the chronically ill. JAMA. 2004;291:2344-50.
21. Brixner DI, Joish VN, Odera GM, Avey SG, Hanson DM, Cannon HE. Effects of benefit design change across 5 disease states.Am J Manag Care. 2007;13(6 pt 2):370-76.
22. Zeber JE, Grazier KL, Valenstein M, Blow FC, Lantz PM. Effect of a medication copayment increase in veterans with schizophrenia. Am J Manag Care. 2007;13(6 pt 2):335-46.
23. Zhang D, Carlson AM, Gleason PP, et al. Relationship of the magnitude of member cost-share and medication persistence with newly initiated renin angiotensin system blockers. J Manag Care Pharm. 2007; 13(8):664-76. Available at: www.amcp.org/data/jmcp/JMCPMaga_664-676.pdf.
24. Schneeweiss S, Patrick AR, Maclure M, Dormuth CR, Glynn RJ. Adherence to statin therapy under drug cost sharing in patients with and without acute myocardial infarction: a population-based natural experiment. Circulation. 2007;115(16):2128-35.
25. Motheral B, Henderson R. The effect of a copay increase on pharmaceutical utilization, expenditures, and treatment continuation. Am J Manag Care. 1999;5(11):1383-94.
26. Fairman KA, Motheral BR, Henderson RR. Retrospective, long-term follow-up study of the effect of a three-tier prescription drug copayment system on pharmaceutical and other medical utilization and costs. Clin Ther. 2003;25(12):3147-66.
27. Huskamp HA, Deverka PA, Epstein AM, Epstein RS, McGuigan KA, Frank RG. The effect of incentive-based formularies on prescription-drug utilization and spending. N Engl J Med. 2003;349(23):2224-32.
28. Roblin DW, Platt R, Goodman MJ, et al. Effect of increased cost-sharing on oral hypoglycemic use in five managed care organizations: how much is too much? Med Care. 2005;43(10):951-59.
29. Fairman KA. The future of prescription drug cost-sharing: real progress or dropped opportunity? J Manag Care Pharm. 2008;14:70-82. Available at: www.amcp.org/data/jmcp/JMCPMaga_JanFeb%2008_070-082.pdf.
30. Lexchin J, Grootendorst P. Effects of prescription drug user fees on drug and health services use and on health status in vulnerable populations: a systematic review of the evidence. Int J Health Serv. 2004;34:101-22.
31. Nichol MB, Venturini F, Sung JC. A critical evaluation of the methodology of the literature on medication compliance. Ann Pharmacother. 1999;33:531-40.
32. Kripalani S, Yao X, Haynes B. Interventions to enhance medication adherence in chronic medical conditions: a systematic review. Arch Intern Med. 2007;167:540-50.
33. Canto de Cetina TE, Canto P, Ordonez Luna M. Effect of counseling to improve compliance in Mexican women receiving depot-medroxyprogesterone acetate. Contraception. 2001;63:143-46.
34. Cote J, Bowie DM, Robichaud P, Parent JG, Battisti L, Boulet LP. Evaluation of two different educational interventions for adult patients consulting with an acute asthma exacerbation. Am J Respir Crit Care Med. 2001;163:1415-19.
35. Gallefoss F, Bakke PS. How does patient education and self-management among asthmatics and patients with chronic obstructive pulmonary disease affect medication? Am J Respir Crit Care Med. 1999; 160:2000-05.
36. Gallefoss F, Bakke PS, Rsgaard PK. Quality of life assessment after patient education in a randomized controlled study on asthma and chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1999;159:812-17.
37. Hill J Bird H, Johnson S. Effect of patient education on adherence to drug treatment for rheumatoid arthritis: a randomised controlled trial. Ann Rheum Dis. 2001;60:869-75.
38. Laporte S, Quenet S, Buchmuller-Cordier A, et al. Compliance and stability of INR of two oral anticoagulants with different half-lives: a randomised trial. Thromb Haemost. 2003;89:458-67.
39. Levy ML, Robb M, Allen J, Doherty C, Bland JM, Winter RJ. A randomized controlled evaluation of specialist nurse education following accident and emergency department attendance for acute asthma. Respir Med. 2000;94:900-08.
40. Morice AH, Wrench C. The role of the asthma nurse in treatment compliance and self-management following hospital admission. Respir Med. 2001;95:851-56.
41. Peterson GM, Fitzmaurice KD, Naunton M, Vial JH, Stewart K, Krum H. Impact of pharmacist conducted home visits on the outcomes of lipid lowering drug therapy. J Clin Pharm Ther. 2004;29:23-30.
42. Pradier C, Bentz L, Spire B, et al. Efficacy of an educational and counseling intervention on adherence to highly active antiretroviral therapy: French prospective controlled study. HIV Clin Trials. 2003;4:121-31.
43. Rawlings MK, Thompson MA, Farthing CF, et al.; NZTA 4006 Helping to Enhance Adherence to Antiretroviral Therapy (HEART) Study Team. Impact of an educational program on efficacy and adherence with a twice-daily lamivudine/zidovudine/abacavir regimen in underrepresented HIV-infected patients. J Acquir Immune Defic Syndr. 2003;34:174-83.
44. Schaffer SD, Tian L. Promoting adherence: effects of theory-based asthma education. Clin Nurs Res. 2004;13:69-89.
45. van Es SM, Nagelkerke AF, Colland VT, Scholten RJ, Bouter LM. An intervention programme using the ASE-model aimed at enhancing adherence in adolescents with asthma. Patient Educ Couns. 2001;44:193-203.
46. Norris SL, Lau J, Smith SJ, Schmid CH, Engelgau MM. Self-management education for adults with type 2 diabetes: a meta-analysis of the effect on glycemic control. Diabetes Care. 2002;25:1159-71.
47. Baird MG, Bentley-Taylor MM, Carruthers SG, et al. A study of efficacy, tolerance and compliance of once-daily versus twice-daily metoprolol (Betaloc) in hypertension. Betaloc Compliance Canadian Cooperative Study Group. Clin Invest Med. 1984;7(2):95-102.
48. Girvin B, McDermott BJ, Johnston GD. A comparison of enalapril 20 mg once daily versus 10 mg twice daily in terms of blood pressure lowering and patient compliance. J Hypertens. 1999; 17:1627-31.
49. Brown BG, Bardsley J, Poulin D, et al. Moderate dose, three-drug therapy with niacin, lovastatin, and colestipol to reduce low-density lipoprotein cholesterol_100 mg/dl in patients with hyperlipidemia and coronary artery disease. Am J Cardiol. 1997;80:111-15.
50. Becker LA, Glanz K, Sobel E, Mossey J, Zinn SL, Knott KA. A randomized trial of special packaging of antihypertensive medications. J Fam Pract. 1986;22:357-61.
51. Friedman RH, Kazis LE, Jette A, et al. A telecommunications system for monitoring and counseling patients with hypertension. Impact on medication adherence and blood pressure control. Am J Hypertens. 1996;9:285-92.
52. Marquez Contreras E, Casado Martinez JJ, Corchado Albalat Y, et al. Efficacy of an intervention to improve treatment compliance in hyperlipidemias. Aten Primaria. 2004;33:443-50.
53. Haynes RB, Sackett DL, Gibson ES, et al. improvement of medication compliance in uncontrolled hypertension. Lancet. 1976;1:1265-68.
54. Johnson AL, Taylor DW, Sackett DL, Dunnett CW, Shimizu AG. Self-recording of blood pressure in the management of hypertension. CMAJ. 1978;119:1034-39.
55. Weber R, Christen L, Christen S, et al. Effect of individual cognitive behaviour intervention on adherence to antiretroviral therapy: prospective randomized trial. Antivir Ther. 2004;9:85-95.
56. Berrien VM, Salazar JC, Reynolds E, McKay K; H. I. V. Medication Adherence Intervention Group. Adherence to antiretroviral therapy in HIV-infected pediatric patients improves with home-based intensive nursing intervention. AIDS Patient Care STDS. 2004;18:355-63.
57. Peterson GM, McLean S, Millingen KS. A randomised trial of strategies to improve patient compliance with anticonvulsant therapy. Epilepsia. 1984;25:412-17.
58. Farber HJ, Oliveria L. Trial of an asthma education program in an inner-city pediatric emergency department. Pediatr Asthma Allergy Immunol. 2004;17:107-15.
59. Brus HL, van de Laar MA, Taal E, RaskerJJ, Wiegman O. Effects of patient education on compliance with basic treatment regimens and health in recent onset active rheumatoid arthritis.Ann Rheum Dis. 1998;57:146-51.
60. Tuldra A, Fumaz CR, Ferrer MJ, et al. Prospective randomized two-arm controlled study to determine the efficacy of a specific intervention to improve long-term adherence to highly active antiretroviral therapy. J Acquir Immune Defic Syndr. 2000;25:221-28.
61. Knobel H, Carmona A, Lopez JL, et al. Adherence to very active anti-retroviral treatment: impact of individualized assessment. Enferm Infecc Microbiol Clin. 1999;17:78-81.
62. Volume CI, Farris KB, Kassam R, Cox CE, Cave A. Pharmaceutical care research and education project: patient outcomes. J Am Pharm Assoc. 2001;41:411-20.
63. Bailey WC, Richards JM Jr, Brooks CM, Soong SJ, Windsor RA, Manzella BA. A randomized trial to improve self-management practices of adults with asthma. Arch Intern Med. 1990;150:1664-68.
64. Piette JD, Weinberger M, McPhee SJ, Mah CA, Kraemer FB, Crapo LM. Do automated calls with nurse follow-up improve self-care and glycemic control among vulnerable patients with diabetes? Am J Med. 2000;108:20-27.
65. Nazareth I, Burton A, Shulman S, Smith P, Haines A, Timberal H. A pharmacy discharge plan for hospitalized elderly patients - a randomized controlled trial. Age Ageing. 2001;30:33-40.
66. Weinberger M, Murray MD, Marrero DG, et al. Effectiveness of pharmacist care for patients with reactive airways disease: a randomized controlled trial. JAMA. 2002;288:1594-602.
67. Coull AJ, Taylor VH, Elton R, Murdoch PS, Hargreaves AD. A randomised controlled trial of senior Lay Health Mentoring in older people with ischaemic heart disease: The Braveheart Project. Age Ageing. 2004;33:348-54.
68. Wysocki T, Greco P, Harris MA, Bubb J, White N H. Behavior therapy for families of adolescents with diabetes: maintenance of treatment effects. Diabetes Care. 2001;24:441-46.
69. Weinberger M, Murray MD, Marrero DG, et al. Issues in conducting randomized controlled trials of health services research interventions in non-academic practice settings: the case of retail pharmacies. HSR: Health Services Research. 2002;37:1067-77.
70. Murray MD, Young J, Hoke S, et al. Pharmacist intervention to improve medication adherence in heart failure. Ann Intern Med. 2007:146:714-25.